Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01230346 · ClinicalTrials.gov registry record · NA
Culturally-Informed Counseling in Latinas at High Risk for Hereditary Breast or Ovarian Cancer
A NA study of Hereditary Ovarian Carcinoma and No Evidence of Disease, sponsored by City of Hope Medical Center.
- Active
- Registry status
- NA
- Development phase
- 493
- Enrollment target
- 3
- Study locations
NCT01230346: Active NA study of Hereditary Ovarian Carcinoma and No Evidence of Disease, sponsored by City of Hope Medical Center.
NCT01230346 is a NA study of Hereditary Ovarian Carcinoma and No Evidence of Disease that is active but no longer recruiting, run by City of Hope Medical Center. The registered enrollment target is 493 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (65% lower). The trial reports 3 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01230346, a NA study of Hereditary Ovarian Carcinoma and No Evidence of Disease, is active but no longer recruiting, sponsored by City of Hope Medical Center.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 493 participants
- Enrollment target
- 3
- Study locations
Study Summary
This pilot clinical trial studies a culturally-informed counseling intervention in Latinas at high risk for hereditary breast or ovarian cancer. A culturally-informed counseling intervention may be an effective method to help people learn more about their cancer risk.
Primary Outcome
Tested using 3 x 3 repeated measures analysis of covariance (ANCOVA)s in which the within subjects variables are anxiety or perceived control, the between groups variable is group membership, and covariates include fatalism and other appropriate moderators.
Conditions Studied
Interventions
- OTHER questionnaire administration
- OTHER survey administration
- OTHER educational intervention
- OTHER counseling intervention
Study Locations (3)
California
- City of Hope Medical Center - Duarte
- University of Southern California-Keck School of Medicine - Los Angeles
- Olive View-UCLA Medical Center - Sylmar
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 493 participants |
| Start Date | 2010-09-03 |
| Est. Completion | 2026-09-25 |
| Phase | NA |
What the registry record for NCT01230346 still lists
NCT01230346 is an interventional study that assigns participants to a tested intervention. The registered 493 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (65% lower).
The record links to 5 conditions, with Hereditary Ovarian Carcinoma appearing as the primary indexed condition, and to 4 interventions - of which questionnaire administration is the first listed.
NCT01230346 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT01230346 about?
NCT01230346 is a clinical study titled "Culturally-Informed Counseling in Latinas at High Risk for Hereditary Breast or Ovarian Cancer". This pilot clinical trial studies a culturally-informed counseling intervention in Latinas at high risk for hereditary breast or ovarian cancer. A culturally-informed counseling intervention may be an effective method to help people learn more about their cancer risk.
What is the current status of trial NCT01230346?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 493 participants. The study started on 2010-09-03. Estimated completion is 2026-09-25.
What conditions does trial NCT01230346 study?
This clinical trial studies the following conditions: Hereditary Ovarian Carcinoma, No Evidence of Disease, BRCA1 Syndrome, BRCA2 Syndrome, Hereditary Female Breast Carcinoma.
What interventions are being tested in trial NCT01230346?
The interventions under investigation include: questionnaire administration (OTHER), survey administration (OTHER), educational intervention (OTHER), counseling intervention (OTHER).
Who is sponsoring clinical trial NCT01230346?
This trial is sponsored by City of Hope Medical Center, which has 582 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01230346 being conducted?
This trial has 3 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hereditary Ovarian Carcinoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01230346's enrollment target sits among peer trials
493 213th of 2000 higher than 1,788 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05861973 · 492 participants · NA
SMARTer Weight Loss Management
- NCT05908331 · 492 participants · NA
MagicTouch for Treatment of In-Stent Restenosis in Coronary Artery Lesions
- NCT06152575 · 492 participants · Phase 3
MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide)
- NCT06953089 · 492 participants · Phase 2
DB-1311 in Combination With BNT327 or DB-1305 in Advanced/Metastatic Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI